ARK Investment Management LLC

Position in ABSI — Absci Corp

CIK 1697748 ST. PETERSBURG, FL

Position in ABSI

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$41,178,507

-$2,623,781 QoQ

Shares Held

13,726,169

+9.4% QoQ

Ownership

8.80%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ARK Investment Management LLC holds $1,308,181,852 across 17 Biotechnology names. ABSI ranks #5 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	11,313,623	$538,189,046
2	BEAM	Beam Therapeutics Inc.	12,133,433	$289,139,708
3	NTLA	Intellia Therapeutics, Inc.	14,509,247	$186,008,546
4	RXRX	Recursion Pharmaceuticals, Inc.	40,212,769	$123,453,200
5	ABSI	Absci Corp This page	13,726,169	$41,178,507
6	NRIX	Nurix Therapeutics, Inc.	1,721,135	$26,677,592
7	PRME	Prime Medicine, Inc.	6,246,827	$21,738,957
8	IONS	Ionis Pharmaceuticals Inc	288,716	$21,679,684

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,178,507	13,726,169	+9.4%	Shares	Sole	2026-05-12
2025-12-31	$43,802,288	12,550,799	+3.2%	Shares	Sole	2026-02-11
2025-09-30	$36,974,829	12,162,773	+21.1%	Shares	Sole	2025-11-12
2025-06-30	$25,818,034	10,045,928	-8.3%	Shares	Sole	2025-07-30
2025-03-31	$27,497,273	10,955,089	+32.5%	Shares	Sole	2025-05-07
2024-12-31	$21,656,752	8,265,936	+30.4%	Shares	Sole	2025-02-04
2024-09-30	$24,209,716	6,337,622	+15.1%	Shares	Sole	2024-10-31
2024-06-30	$16,951,975	5,503,888	+68.0%	Shares	Sole	2024-07-26
2024-03-31	$18,613,893	3,277,094	—	Shares	Sole	2024-04-18
No filing history on record for this holder in this stock.